BioMarin Pharmaceutical Inc (BMRN.xnas)

BioMarin Pharmaceutical Inc (BMRN.xnas)

Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

BioMarin Pharmaceutical Inc (BMRN.xnas) Profile

BioMarin Pharmaceutical Inc (BMRN.xnas) is a world-leading biotechnology company headquartered in California, America. BioMarin operates in the United States, South America, Asia, and Europe with 34 offices locations in 20 countries and they will continue to expand into new markets and grow their team. BioMarin develops and commercialises first in class therapies for rare genetic diseases and it is a pioneer in treatments for debilitating and life-threatening conditions with business and research in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I) and the first to provide therapeutics for phenylketonuria (PKU). The company employes 3,000 people and has $1.7B (USD) in 2019 yearly revenue. BioMarin Pharmaceutical Inc stock (BMRN.xnas) is listed on NASDAQ and had a market capitalisation of $15.47B (USD) as of December 2021. The biotech sector has been in focus as of November 2021 due to the COVID-19 pandemic with drug approvals, with BioMarin being approved for Voxzogo injection. BioMarin plans to use the ongoing open-label extension studies to fulfil the post-marketing requirements of continued approval.

Holding cost
Trading hours in US Eastern Time

Start Trading BioMarin Pharmaceutical Inc (BMRN.xnas)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as acciones, commodities, y foreign exchange, y índices.

6 razones para operar CFD sobre acciones con FP Markets

Regulado en Australia
Bróker de forex y CFD

A largo o a corto

Increase your ability to profit in all market conditions Leverage options up to 20:1

Ejecución DMA
(Acceso directo al mercado)

Precios de acciones transparentes
y en tiempo real Control, funcionalidad y liquidez abundante
Total profundidad de mercado
y vista de órdenes en la cola

Plataformas avanzadas
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

Soporte multilingüe 24/7

Award winning support & personal account managers

Exposición global

Márgenes bajos y comisiones competitivas en +10.000 productos en acciones globales en cuatro continentes

Gana dividendos

On long positions No ownership of physical shares necessary

Empieza a hacer trading
en cuestión de minutos.

Abre una cuenta ahora

bullet Accede a más de 10.000 instrumentos financieros
bullet Apertura y cierre automático de posiciones
bullet Noticias y agenda económica
bullet Indicadores técnicos y gráficos
bullet Muchas más herramientas incluidas

Al proporcionar su correo electrónico, usted acepta la política de privacidad de FP Markets y está de acuerdo en recibir futuros mensajes de marketing por parte de FP Markets. Puede darse de baja en cualquier momento.

Get instant Updates in Telegram
Mapa del sitio | © FP Markets 2022